loading

Inovio Pharmaceuticals Inc Azioni (INO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- 0.0653 0.1008 -
Operating Expenses
8.12%
21.21
23.08 25.12 33.30 31.48
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
8.12%
21.21
23.08 25.12 33.30 31.48
Operating Income/Loss
8.12%
-21.21
-23.08 -25.05 -33.20 -31.48
Income/Loss From Continuing Operations Before Tax
93.44%
-45.50
-23.52 -19.69 0.1008 -30.47
Income/Loss From Continuing Operations After Tax
93.44%
-45.50
-23.52 -19.69 -32.24 -30.47
Net Income/Loss
93.44%
-45.50
-23.52 -19.69 -32.24 -30.47
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
34.35%
52.17
38.83 38.61 27.20 23.29
Diluted Average Shares
34.35%
52.17
38.83 38.61 27.20 23.29
Basic Earnings Per Share
42.62%
-0.87
-0.61 -0.51 -1.19 -1.31
Diluted Earnings Per Share
42.62%
-0.87
-0.61 -0.51 -1.19 -1.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$27.93
price down icon 2.17%
$49.46
price down icon 1.22%
$95.89
price down icon 7.39%
$133.99
price down icon 2.01%
$142.38
price down icon 0.34%
ONC ONC
$293.75
price down icon 0.64%
Capitalizzazione:     |  Volume (24 ore):